Conavi Medical Provides Shareholder Update and 2025 Outlook
23. Januar 2025 07:00 ET
|
Conavi Medical Corp.
- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026- Evolving medical guidelines position next-generation Novasight...
[Latest] Global Intravascular Ultrasound Devices Market Size/Share Worth USD 1214.6 Million by 2033 at a 6.87% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
23. Januar 2025 02:30 ET
|
Custom Market Insights
Austin, TX, USA, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Intravascular Ultrasound Devices Market Size, Trends and Insights By Product...
Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review
07. Januar 2025 07:00 ET
|
Conavi Medical Corp.
TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing,...
Conavi Medical Announces Grant of Stock Options
06. Januar 2025 07:37 ET
|
Conavi Medical Corp.
TORONTO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“Conavi Medical” or the “Company”) announced that its board of directors (the “Board”) has approved grants of stock...
Conavi Medical Reports Fiscal 2024 Financial Results and Operational Highlights
19. Dezember 2024 07:00 ET
|
Conavi Medical Corp.
– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million...
Conavi Medical to Participate in the MedInvest MedTech, AI & Digital Health Conference
10. Dezember 2024 08:30 ET
|
Conavi Medical Inc.
– Marks first time as a public company that Conavi is presenting at an investor event – – Live webcast presentation on Wednesday, December 11ᵗʰ at 3:35 p.m. ET – TORONTO, Dec. 10, 2024 (GLOBE...
China's NMPA Approves EOM’s Coronary Imaging System Based on Conavi Medical’s IP
09. Dezember 2024 08:15 ET
|
Conavi Medical Inc.
– Approval triggers fourth and final US$5.9 million milestone payment to Conavi Medical, which it will use to extinguish the promissory note owed by it to EOM – – Conavi Medical eligible to receive...
JACC: Cardiovascular Interventions Publishes Peer-Reviewed Article on Emerging Hybrid Intracoronary Imaging Technologies
28. Oktober 2024 08:15 ET
|
Conavi Medical Inc.
– Conavi Medical’s Novasight Hybrid™ System is the first technology to combine both IVUS and OCT to enable simultaneous and co-registered imaging of coronary arteries – – Company showcasing its...
Conavi Medical Corp. Commences Trading on TSX-V Under Symbol “CNVI”
16. Oktober 2024 07:30 ET
|
Conavi Medical Inc.
TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“Conavi” or the “Company”) (TSXV: CNVI) is pleased to announce that, pursuant to its press releases...
Intravascular Ultrasound [IVUS] Devices Market to Grow at a 5.9% CAGR from 2023 to 2031, reaching USD 1240 million: TMR Report
09. Juni 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 09, 2023 (GLOBE NEWSWIRE) -- The global intravascular ultrasound [IVUS] devices market is anticipated to grow at a 5.9% CAGR from 2023 to 2031. A market...